Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
OmicsBank raises $2.25M in seed funding from Redesign Health to expand its clinical data infrastructure for drug development and healthcare AI.
PRIVATEAug 25, 2026•about 3 hours ago
Amount Raised
$2.25 Million
Round Type
Seed
San FranciscoInformation TechnologyBiotechnologyHealth CareArtificial IntelligenceMachine Learning
Investors
Redesign Health
Description
OmicsBank, a clinical data infrastructure company, announced $2.25 million in seed funding from Redesign Health. This investment will support their U.S. expansion and enhance access to clinical data from Asia. The aim is to increase representation in drug development and healthcare AI
Company Information
Company
OmicsBank
Location
San Francisco, California, United States
About
OmicsBank is a clinical data infrastructure company that connects fragmented hospital data for drug development and healthcare AI. Founded in 2025, it aims to close the representation gap in global drug development by providing access to clinical and multi-omics data from Asia. The company's technology standardizes and de-identifies multimodal data within hospitals, supporting diverse and comprehensive research. OmicsBank is building a data network that integrates clinical events with imaging and multi-omics information for drug developers and AI teams.
Don't miss OmicsBank's next move
Get an email the moment OmicsBank raises, hires an exec, or expands, usually minutes after it happens.